Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gout].

I Carey Berner1, J Dudler

  • 1Service de rhumatologie, médecine physique et rehabilitation CHUV, Lausanne.

Revue Medicale Suisse
|February 9, 2006
PubMed
Summary
This summary is machine-generated.

Gout is a chronic disease linked to high uric acid levels, a potential risk factor for cardiovascular issues. Treatment is recommended for symptomatic gout, not asymptomatic hyperuricemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Drug therapy of pain: reason overwhelmed by emotion?].

Revue medicale suisse·2013
Same author

[Diffuse sclerosing osteomyelitis of the mandible and SAPHO].

La Revue de medecine interne·2012
Same author

Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

[Arthritis, erythema nodosum and genital ulcerations. Behçet disease].

Praxis·2011
Same author

[Rheumatoid arthritis and ankylosing spondylitis-rheumatologic highlights 2009].

Revue medicale suisse·2010
Same author

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Annals of the rheumatic diseases·2009
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Area of Science:

  • Rheumatology
  • Cardiology
  • Pharmacology

Context:

  • Gout is a chronic systemic disease with serious potential complications.
  • Elevated uric acid levels (hyperuricemia) may independently increase cardiovascular disease risk, particularly in high-risk patients.

Purpose:

  • To review the systemic nature of gout and the role of hyperuricemia in cardiovascular disease.
  • To discuss current treatment guidelines for gout and hyperuricemia and emerging therapeutic options.

Summary:

  • Gout should be viewed as a chronic, systemic illness with significant potential sequelae.
  • Hyperuricemia is likely an independent risk factor for cardiovascular diseases, especially in high-risk individuals.
  • Current evidence does not support treating asymptomatic hyperuricemia.

Related Experiment Videos

Impact:

  • Highlights the systemic impact of gout and the cardiovascular risks associated with hyperuricemia.
  • Informs clinical practice regarding the treatment of asymptomatic hyperuricemia.
  • Provides an overview of current and emerging pharmacotherapies for chronic gout, including allopurinol, febuxostat, and pegylated uricase.